ABVC
ABVC BIOPHARMA, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.91
−0.86%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 0.72x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 78.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.36x
- Price / sales
- -30.52x
- Price / cash flow
- -9.03x
Enterprise value
- Enterprise value
- $27.9M
- EV / sales
- -35.11x
- EV / EBITDA
- -3.61x
- EV / EBIT
- -3.82x
- Market cap
- $24.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026